Alzheimers Archives - Page 2 of 3 - Australian Biotech Company News

Home Tags Alzheimers

Biotechnology

Atomic Structure of Alzheimer’s Amyloid Protein Reveals New Toxicity Mechanism

BioChannel - June 29, 2020

Biotechnology

Alzheimer’s Disease Protein Clearance Mechanism Identified

BioChannel - February 19, 2020

Biotechnology

Trial Triumphs, Takeover Talk Boost Reata Pharmaceuticals

BioChannel - February 10, 2020

Biotechnology

In Alzheimer’s, New Protein Is Seen at Heart of Plaque Formation

BioChannel - January 22, 2020

Biotechnology

Neurodegenerative Treatments Build to a Tipping Point

BioChannel - January 17, 2020

Biotechnology

Biogen Shares Surge after Reversal on Alzheimer’s Candidate Aducanumab

BioChannel - October 22, 2019

Biotechnology

Lilly Making First Milestone Payment in $1.9B Collaboration with AC Immune

BioChannel - September 20, 2019

Biotechnology

Alzheimer’s Disease Shows Up Early as Retinal Thinning and Thickening

BioChannel - September 16, 2019

Biotechnology

Alzheimer’s Memory Loss Could Be Treated with Calcium Channel Blocker

BioChannel - September 12, 2019

Biotechnology

Novel Chimeric Rodent Model Yields Vital Information about Alzheimer’s

BioChannel - August 1, 2019

123 Page 2 of 3

Stay connected

Recent posts

Researchers create first comprehensive functional map of genes expressed in human cells

BioChannel - June 9, 2022

Are we born with a moral compass?

BioChannel - June 9, 2022

Ziphius Vaccines and University of Antwerp to work on RNA-based delivery methods

BioChannel - June 9, 2022

Random article

Researchers create first comprehensive functional map of genes expressed in human...

Are we born with a moral compass?

Ziphius Vaccines and University of Antwerp to work on RNA-based delivery...

Alzheimer’s Pathology Could Benefit from Activating Microglial Targets of Rapamycin